Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial (Q34817061)

4 August 2017

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial (English)

1 reference

4 August 2017

0 references

0 references

0 references

chronic heart failure

1 reference

Aldo P Maggioni

2

0 references

Luigi Tavazzi

1

object named as

Luigi Tavazzi

1 reference

4 August 2017

Roberto Marchioli

3

1 reference

4 August 2017

Simona Barlera

4

1 reference

4 August 2017

Maria Grazia Franzosi

5

1 reference

4 August 2017

Roberto Latini

6

1 reference

4 August 2017

Donata Lucci

7

1 reference

4 August 2017

Gian Luigi Nicolosi

8

1 reference

4 August 2017

Maurizio Porcu

9

1 reference

4 August 2017

Gianni Tognoni

10

1 reference

4 August 2017

Gissi-HF Investigators

11

1 reference

4 August 2017

language of work or name

English

0 references

publication date

29 August 2008

1 reference

4 August 2017

1 reference

4 August 2017

372

1 reference

4 August 2017

1231-1239

1 reference

4 August 2017

9645

1 reference

Spectrum of pleiotropic effects of statins in heart failure

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Anti-inflammatory effects of statins: clinical evidence and basic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Beneficial effects of statins on endothelial dysfunction and vascular stiffness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Meta-analysis of effect of statin treatment on risk of sudden death

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Observational studies of statins in systolic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Statins and symptomatic chronic systolic heart failure: a post-hoc analysis of 5010 patients enrolled in Val-HeFT

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Statin therapy is associated with lower mortality among patients with severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Usefulness of atorvastatin in patients with heart failure due to inflammatory dilated cardiomyopathy and elevated cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Rosuvastatin in older patients with systolic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

The impact of coenzyme Q10 on systolic function in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Altered intestinal function in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

The cholesterol paradox revisited: heart failure, systemic inflammation, and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Clinical investigations of statins in heart failure: ventricular function and anti-remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

Controlled Rosuvastatin Multinational Trial In Heart Failure (the positive negative trial).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

The role of statins in the prevention of heart failure after acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961240-4

7 January 2021

10.1016/S0140-6736(08)61240-4

Identifiers

DOI

1 reference

4 August 2017

1 reference